Ductal carcinoma in situ of the human breast: Clinico-pathological aspects

Annali Italiani di Chirurgia

Volumn 70, Issue 3, 1999, Pages 343-347

  Pinder, S E ^a   Evans, A J ^a   Ellis, I O ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; TAMOXIFEN;

ADJUVANT CHEMOTHERAPY; BIOPSY; BREAST; BREAST TUMOR; CARCINOMA IN SITU; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; FEMALE; HUMAN; MAMMOGRAPHY; MULTIMODALITY CANCER THERAPY; PAGET NIPPLE DISEASE; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; REVIEW; TUMOR RECURRENCE;

ANTINEOPLASTIC AGENTS, HORMONAL; BIOPSY; BREAST; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MAMMOGRAPHY; NEOPLASM RECURRENCE, LOCAL; RANDOMIZED CONTROLLED TRIALS; TAMOXIFEN;

EID: 0033127069     PISSN: 2239253X     EISSN: 2239253X     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Frykberg E.R., Bland K.I.: Overview of the biology and management of ductal carcinoma in situ of the breast. Cancer, 74:350-361, 1994.
2. Fisher E.R., Sass R., Fisher B., Wicherham L., Paik S.M.: Pathologic findings from the National Surgical Adjuvant Breast Project (protocol 6). I. Intraductal carcinoma (DCIS). Cancer, 57:197-208, 1986.
3. Page D.L., Dupont W.D., Rogers L.W., Landenberger M.: Intraductal carcinoma of the breast: Follow up afier biopsy alone. Cancer, 49:751-758, 1982.
4. Betsill W.L.J., Rosen P.P., Lieberman P.H., Robbins G.F.: Intraductal carcinoma. Long-term follow-up afier treatment by biopsy alone. JAMA, 239:1863-1867, 1978.
5. Ketcham A., Moffat F.: Vexed surgeons, perplexed patients, and breast cancer which may not be cancer. Cancer, 65:387-393, 1990.
6. Crissman J.D., Visscher D.W., Kubus J.: Image cytophotometric DNA analysis of atypical hyperplasias and intraductal carcinomas of the breast. Arch Pathol Lab Med, 114:1249-1253, 1990.
7. Lodato R.F., Maguire H.J., Greene M.I., Weiner D.B., Li Volsi V.A.: Immunohistochemical evaluation of c-erbB-2 oncogene expression in ductal carcinoma in situ and atypical hyperplasia of the breast. Mod Pathol, 3:449-454, 1990.
8. Poller D.N., Roberts E.C., Bell J.A., Elston C.W., Blarney R.W., Ellis LO.: p53 protein expression in mammary ductal carcinoma in situ: relationship to immunohistochemical expression of estrogen receptor and c-erbB-2 protein. Hum Pathol, 24:463-468, 1993
9. Bobrow L.G., Happerfield L.C., Gregory W.M., Springall R.D., Millis R.R.: The classification of ductal carcinoma in situ and its association with biological markers. Semin Diagn Pathol, 11:199-207, 1994.
10. Leal C.B., Schmitt F.C., Bento M.J., Maia N.C., Lopes C.S.: Ductal carcinoma in situ of the breast. Histologic categorization and its relationship to ploidy and immunohistochemical expression of hormone receptors, p53 and c-erbB-2 protein. Cancer, 75:2123-2131, 1995.
11. van Dongen J.A., Holland R., Peterse J.L. et al.: Ductal carcinoma in-situ of the breast; second EORTC consensus meeting. Eur J Cancer, 28:626-629, 1992.
12. Quinn C.M., Ostrowski J.L.: Cytological and architectural heterogeneity in ductal carcinoma in situ of the breast. J Clin Pathol, 50:596-599, 1997.
13. Liberman L., Cohen M.A., Dershaw D.D., Abramson A.F., Hann L.E., Rosen P.P.: Atypical ductal hyperplasia diagnosed at stereotaxic core biopsy of breast lesions: an indication for surgical biopsy. Ajr Am J Roentgenol, 164:1111-1113, 1995.
14. National Coordinating Group for Breast Screening Pathology: Pathology Reporting in Breast Cancer Screening. (Second ed.) Sheffield: NHSBSP Publications, 1995.
15. Holland R., Peterse J.L., Millis R.R. et al.: Ductal carcinoma in situ: A proposal for a new classification. Semin Diagn Pathol, 11:167-180, 1994.
16. Lampejo O.T., Barnes D.M., Smith P., Millis R.R.: Evaluation of infiltrating ductal carcinoma with a DCIS component: correlation of the histologic type of the in situ component with grade of the infiltrating component. Semin Diagn Pathol, 22, 1994.
17. Silverstein M.J., Poller D.N., Waisman J.R. et al.: Prognostic Ductal Carcinoma In Situ of the Human Breast: Clinico-pathological aspects classification of breast ductal carcinoma-in-situ. Lancet, 345:1154-1157, 1995.
18. Poller D.N., Silverstein M.J., Galea M. et al.: Ideas in pathology. Ductal carcinoma in situ of the breast: a proposal for a new simplified histological classification association between cellular proliferation and c-erbB-2 protein expression. Mod Pathol, 7:257-62, 1994.
19. Douglas-Jones A.G., Gupta S.K., Attanoos R.L., Morgan J.M., Mansel R.E.: A critical appraisal of six modern classifications of ductal carcinoma in situ of the breast (DCIS): correlation with grade of associated invasive carcinoma. Histopathology, 29:397-409, 1996.
20. Guerry P., Erlandson R.A., Rosen P.P.: Cystic hypersecretory hyperplasia and cystic hypersecretory duct carcinoma of the breast. Pathology, therapy, and follow-up of 39 patients. Cancer, 61:1611-20, 1988.
21. Fisher E.R., Brown R.: Intraductal signet ring carcinoma: A hitherto undescribed form of intraductal carcinoma of the breast. Cancer, 55:2533-2537, 1985
22. Cross A.S., Azzopardi J.G., Krausz T., van Noorden S., Polak J-M.: A morphological and immunocytochemical study of a distinctive variant of ductal carcinoma in-situ of the breast. Histopathol, 9:21-37, 1985
23. Eusebi V., Foschini M.P., Cook M.G., Berrino F., Azzopardi JG.: Long-term follow-up of in situ carcinoma of the breast with special emphasis on clinging carcinoma. Semin Diagn Pathol, 6:165-173, 1989.
24. van Dongen J.A., Fentiman I.S., Harris J.R. et al.: In-situ breast cancer: the EORTC consensus meeting. Lancet, 2:25-7, 1989.
25. Faverly D.R., Burgers L., Bult P., Holland R.: Three-dimensional imaging of mammary ductal carcinoma in situ: clinical implications. Semin Diagn Pathol, 11:193-198, 1994.
26. Lagios M.D.: Duct carcinoma in situ. Pathology and treatment. Surg Clin North Am, 70:853-71, 1990.
27. Evans A.J., Pinder S.E., Wilson A.R.M. et al.: Ductal carcinoma in situ of the breast: correlation between mammographic and pathologic findings. AJR, 162:1307-1311, 1994.
28. Holland R., Hendriks J.H.C.L.: Microcalcifications associated with ductal carcinoma in situ: mammographic-pathologic correlation. Semin Diagn Pathol, 11:181-192, 1994.
29. Holland R, Hendriks J.H.C.L., Verbeek A.L.M., Mravunac M., Schuurmans Stekhoven J.H.: Extent, distribution and mammographic/histological correlations of breast ductal carcinoma in situ. Lancet, 335:519-522, 1990.
30. Bellamy C.O., McDonald C., Salter D.M., Chetty U., Anderson T.J.: Noninvasive ductal carcinoma of the breast: the relevance of histologic categorization. Hum Pathol, 24:16-23, 1993.
31. Recht A., Van D.J., Fentiman I.S., Holland R, Peterse J.L.: Third meeting of the DCIS Working Party of the EORTC - Conference report. Eur J Cancer, 28:626-629, 1994.
32. Fisher E.R., Constantino J., Fisher B., Palekar A.S., Redmond C., Mamounas E.: Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ). Cancer, 75:1310-1319, 1995.
33. Silverstein M.J., Gierson E.D., Colburn W.J. et al.: Can intraductal breast carcinoma be excised completely by local excision? Clinical and pathologic predictors. Cancer, 73:2985-2989, 1994.
34. Silverstein M.J., Lagios M.D., Craig P.H. et al.: A prognostic index for ductal carcinoma in situ of the breast. Cancer, 77:2267-2274, 1996.
35. Recht A., Rutgers E.J.T., Fentiman I.S., Kurtz J.M., Mansel R.E., Sloane J.M.: The Fourth EORTC DCIS Consensus Meeting: Conference Report. 1998. Submitted for publication to the Eur J Cancer.